Efficacy of omalizumab treatment in a man with occupational asthma and eosinophilic granulomatosis with polyangioitis

Omalizumab is a humanized monoclonal antibody that binds to free-circulating immunoglobulin E (IgE). Several studies have shown the clinical efficacy of omalizumab in severe, persistent allergic asthma, including occupational cases.1

http://ift.tt/2E8Ip23